Home LiteratureArticle Details
PMID: 20587410 Published · ppublish English

Risk of breast cancer in male BRCA2 carriers.

Journal of medical genetics ·Vol. 47 ·No. 10 ·2011-01-28

Evans D G R, Susnerwala I, Dawson J, Woodward E, Maher E R, Lalloo F

Abstract

The risk of breast cancer for unaffected men who test positive for a BRCA2 mutation is based on very few retrospective studies. We have used both retrospective and prospective analysis in 321 families with pathogenic BRCA2 mutations. Three breast cancers occurred in male first-degree relatives after family ascertainment in 4140 years of follow-up suggesting a risk of breast cancer to 80 years of 8.9%. A second analysis excluding index cases identified 16 breast cancers in 905 first-degree male relatives on which Kaplan-Meier analysis was performed after assigning carrier status. This analysis confirmed that breast cancer risk in men was 7.1% (SE 5.2-8.6%) by age 70 years and 8.4% (SE 6.2-10.6%) by age 80 years.

Article Info
Journal
Journal of medical genetics
Abbr.
J Med Genet
Published
2011-01-28
Indexed
2010-10-06
Updated
2016-11-22
Language
English
Country/Region
England
NLM ID
2985087R
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com